Australia's Griffith University joins $280 M partnership to deliver mRNA vaccine outcomes

Queensland will become a global mRNA vaccine hub with leading healthcare company Sanofi partnering with Griffith Univers...

December 7, 2022 | Wednesday | News
Vaxxas raises A$34 M to clinically advance needle-free vaccines

Vaxxas has completed a financing round which raised $23 million (A$34 million) in new funds. This investment round was l...

December 6, 2022 | Tuesday | News
Australian firm Immutep partners with Merck and Pfizer for cancer treatment

Australia's Immutep has signed a Clinical Trial Collaboration and Supply Agreement with Merck KGaA, Darmstadt, Germany a...

November 30, 2022 | Wednesday | News
Sonic Healthcare acquires stake in Australian startup Microba Life Sciences for $17.8 M

Australian startup Microba Life Sciences has announced that leading medical diagnostics provider Sonic Healthcare&n...

November 29, 2022 | Tuesday | News
Australia takes aim at next pandemic threat with new vaccine platform

Norway-based CEPI, the Coalition for Epidemic Preparedness Innovations, is to put $5.7 million (AU$8.5 million) into the...

November 28, 2022 | Monday | News
Australia's IonOpticks ushers in new age of proteomics with launch of Aurora Frontier

The field of proteomics is set to be revolutionised with the launch of Australia-based IonOpticks' Aurora Frontier that ...

November 25, 2022 | Friday | News
Australia develops sperm syringe offering new hope to infertile couples

Australia's Monash University-developed syringe that uses a 3D filter to detect viable sperm can increase sperm quality ...

November 24, 2022 | Thursday | News
State-of-the-art medical education facilities open in Dubbo, Australia

New state-of-the-art medical education facilities have officially opened at the University's School of Rural Health in D...

November 21, 2022 | Monday | News
Australia's Immuron completes strategic investment in UK's startup Ateria Health

Australia's Immuron Limited has completed a strategic investment in Ateria Health Limited, a UK based company that ...

November 21, 2022 | Monday | News
Australia offers new nasal vaccine strategy to improve COVID-19 protection

Researchers from the Centenary Institute and the University of Sydney in Australia have developed a new nasal vaccinatio...

November 17, 2022 | Thursday | News
Australia picks Lunit's AI-based solution for breast cancer screening

South Korea-based startup Lunit has signed a contract to supply its artificial intelligence (AI) solution for the Breast...

November 18, 2022 | Friday | News
Australia to work towards expanding insulin access

The Australian Government is changing the lives for the 130,000 Australians living with type 1 diabetes by subsidis...

November 14, 2022 | Monday | News
Australian startup EpiAxis partners with Seattle Children's Research Institute

Australia-based startup EpiAxis Therapeutics has signed a material transfer agreement (MTA) with Seattle Children’...

November 10, 2022 | Thursday | News
Australian firm Telix acquires US-based Optimal Tracers

Australia-based Telix Pharmaceuticals has entered into an agreement with Sacramento-based Northern California PET Imagin...

November 14, 2022 | Monday | News
Australia launches global artificial heart competition

A team of Australia's Monash University biomedical engineering students has launched a global artificial heart competiti...

November 14, 2022 | Monday | News
Bridgewest to acquire Pfizer's injectable manufacturing plant in Australia

US-based Bridgewest Group has announced the signing of a definitive agreement to purchase the sterile injectable manufac...

November 11, 2022 | Friday | News
CSIRO partnership helps connect Australian healthcare system

The Australian Digital Health Agency and Australia’s national science agency, Commonwealth Scientific and Industri...

November 10, 2022 | Thursday | News
Australia announces world first regulatory approval for donor derived microbiome drug

Australian startup BiomeBank has announced the first regulatory approval for a donor derived microbiome drug product wor...

November 9, 2022 | Wednesday | News
Changing treatment can help patients with multiple sclerosis Australian study

Australia's Monash University researchers have used the world’s largest multiple sclerosis (MS) registry, MSBase, ...

November 9, 2022 | Wednesday | News
New biotech incubator in Australia to drive translation of world-class medical research

The University of Melbourne, the Walter and Eliza Hall Institute (WEHI), and CSL in Australia have appointed an independ...

November 8, 2022 | Tuesday | News
Australia working towards reducing emissions in healthcare

Australia-based Monash University experts, along with an international group of researchers, have highlighted the need t...

November 7, 2022 | Monday | News
CSL signs $4 B agreement with Arcturus Therapeutics for self-amplifying mRNA vaccines

US-based Arcturus Therapeutics Holdings Inc. has announced a strategic collaboration with CSL Seqirus, a global vaccine ...

November 4, 2022 | Friday | News
Australia gives $6.5 M support for children with hearing loss

The Australian government has delivered on a key election commitment and has provided $6.5 million to The Shepherd Centr...

November 3, 2022 | Thursday | News
Australia's Nuheara receives historic US FDA clearance for self-fitting OTC hearing aids

Medical device and consumer electronics manufacturer at Australia, Nuheara has received US Food and Drug Administration ...

November 2, 2022 | Wednesday | News
ANDHealth to foster Western Australia's Digital Health Companies

ANDHealth, Australia’s leading digital health commercialisation organisation, has launched the WA Connected H...

November 2, 2022 | Wednesday | News